Backgrounds of patients with Parkinson’s disease
| Total No of patients | 38 |
|---|---|
| Age (y) (mean (SD)) | 65.8 (8.8) |
| Duration of illness (y) (mean (SD)) | 7.4 (7.8) |
| Hoehn and Yahr stage (No of cases) | |
| Stage I | 4 |
| Stage II | 19 |
| Stage III | 7 |
| Stage IV | 8 |
| Stage V | 0 |
| WAIS-R scores (mean (SD)) | |
| Full IQ | 93.8 (13.6) |
| Verbal IQ | 98.5 (14.6) |
| Performance IQ | 89.9 (13.5) |
| Levodopa dosage1-150 (38 cases) (mg/day) (mean (SD)) | 367.2 (158.4) |
| Trihexyphenidyl dosage (12 cases) (mg/day) (mean (SD)) | 6 (4.1) |
↵1-150 The levodopa dosage in the table represents the dosage of levodopa in Neodopaston® which contains levodopa and carbidopa.